AI-Developed Drugs Are on Their Way to Becoming Reality

AI is driving a revolution in drug development - the first AI-developed drugs could start being tested as soon as this year. How fast could this change healthcare?

Share
AI-Developed Drugs Are on Their Way to Becoming Reality

Four years ago, Alphabet's subsidiary Isomorphic Labs took a big step toward using artificial intelligence to create cheaper, more effective drugs. Now founder Demis Hassabis says the first AI-developed drugs could start being tested as early as the end of the year.

Shorter Time From Research to Finished Drug

Traditionally, it takes between five and ten years to develop a new drug, but with the help of AI, the process could be drastically shortened. According to Hassabis, development could go up to ten times faster, which would mean a revolution in healthcare.

- If we succeed with this, it could have a huge impact on people's health, says Demis Hassabis in an interview with the Financial Times.

Partnerships With Major Pharmaceutical Companies

To realize his vision, Isomorphic Labs has established partnerships with several leading pharmaceutical companies, including Eli Lilly and Novartis. This means AI-developed drugs could reach the market faster once testing is complete.

Nobel Prize for Groundbreaking AI Work

Demis Hassabis, who recently received the Nobel Prize in Chemistry, is a central figure in this development. The prize was shared with David Baker and John M. Jumper for their work in protein structure prediction, a technology that's also crucial for AI-driven drug development.